Publication | Closed Access
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
2.2K
Citations
18
References
1994
Year
The antiglutamate agent riluzole appears to slow the progression of amyotrophic lateral sclerosis, and it may improve survival in patients with disease of bulbar onset.
| Year | Citations | |
|---|---|---|
Page 1
Page 1